Identity
Glutathione is a tripeptide studied in multiple formulations and clinical contexts.
Selected study only; not a complete clinical review.
Peptide library
Glutathione
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
The controlled oral study in children with cystic fibrosis was neutral on growth and measured inflammation. It neither proves general wellness benefits nor assesses IV skin-lightening or anti-aging use.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
Children aged 2–10 with pancreatic-insufficient cystic fibrosis; randomized oral study.
What the sources found
Oral supplementation did not significantly improve growth or measured inflammatory markers versus placebo over 24 weeks.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
Glutathione is a tripeptide studied in multiple formulations and clinical contexts.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Reported adverse effects
- Reported tolerability in this pediatric oral trial does not establish injectable safety.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
Oral supplementation did not significantly improve growth or measured inflammatory markers versus placebo over 24 weeks.
Selected study only; not a complete clinical review.
Adverseeffects
Reported tolerability in this pediatric oral trial does not establish injectable safety.
Selected study only; not a complete clinical review.
References
Oral Glutathione and Growth in Cystic Fibrosis: A Multicenter, Randomized, Placebo-controlled, Double-blind Trial. 2020.
PMID: 32960827
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.